CND Intersessional meeting - Thematic discussions on the implementation of all international drug policy commitments following up to the 2019 Ministerial Declaration (November 2024)

When? 12 - 14 November 2024
Where? Vienna International Centre (BR-D, 4th floor, C-Building) - Austria

At its 67th session in March 2024 the Commission on Narcotic Drugs (CND) adopted by consensus the 'High-level declaration by the Commission on Narcotic Drugs on the 2024 midterm review, following up to the Ministerial Declaration of 2019'.

Following the format used for the thematic discussions held within the CND since 2016, Member States developed a multi-year workplan and will hold, every autumn, inter-active meetings aiming to address the challenges identified in the “stock taking”- part of the 2019 Ministerial Declaration.

The first of these thematic intersessionals will take place 12-14 November 2024 in Vienna, Austria. The meeting will be held in a hybrid-format, combining an in-person component with online participation.

The following topics will be covered. (Please also consult the organizational arrangements for the meeting that contain additional information):

12 November 2024: Expanding range of drugs and synthetic opioids and nonmedical use of prescription drugs

• Morning session (10AM to 1PM CET): Expanding range of drugs and diversifying markets.
• Afternoon session (3PM to 6PM CET): Synthetic opioids and non-medical use of prescription drugs.

13 November 2024: Illicit cultivation, production, and trafficking

• Morning session (10AM to 1PM CET): Challenges in illicit cultivation and production of narcotic drugs and psychotropic substances.
• Afternoon session (3PM to 6PM CET): Illicit trafficking in substances and precursors, and domestic diversion of precursor chemicals.

14 November 2024: Scheduling Challenges and Other Substantive Matters

• Morning session (10AM to 1PM CET): Legal, scientific, and regulatory challenges in scheduling substances.
• Afternoon session (3PM to 6PM CET): Other substantive matters (to allow discussion of persistent, new, or emerging issues of particular concern).

All of the thematic panel discussion also provide an opportunity to discuss cross-cutting issues, including those identified in the "way forward" part of the 2024 CND High-Level Declaration:

• Cooperation at all levels.
• Data collection and analysis.
• Technological innovation.

Side events

Evidence-Based Drug Policies and Harm Reduction Strategies
Tuesday, 12 November 2024 / 13:30 - 14:45 PM

More information here